TGen method isolates biospecimens for treatment of kidney disease
PHOENIX, Ariz. — July 11, 2012 — Researchers at the Translational Genomics Research Institute (TGen) have developed a method of isolating biospecimens that could lead to a less costly, less invasive and more accurate way of diagnosing chronic kidney disease, or CKD.
CKD is a major complication of diabetes, high blood pressure and a form of kidney disease known as glomerulonephritis, which is characterized by a progressive deterioration of the kidney's ability to filter waste from the blood.
TGen's customized procedure produced high amounts of protein-rich urinary exosomes, ...